WebDisclosure WebDisclosure
Basculer en Français
9554 Companies
188638 Keywords
120425 Articles
100704 Press releases
Headlines Articles Press releases Bux Pain Management Remove
  1. Home
  2. Companies
  3. Bux Pain Management
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/02/2024 at 17:05, 1 year 8 months ago

    Bux Pain Management Launches SynchroMed III Pain Pump

    FDA Approval Chronic Pain Treatment SynchroMed III Pump Pain Management Technology Opioid Alternative
  • BRIEF

    published on 04/02/2024 at 17:05, 1 year 8 months ago

    Bux Pain Management lance la pompe anti-douleur SynchroMed III

    Traitement De La Douleur Chronique Approbation De La FDA Pompe SynchroMed III Technologie De Gestion De La Douleur Alternative Aux Opioïdes
  • PRESS RELEASE

    published on 04/02/2024 at 17:00, 1 year 8 months ago

    Bux Pain Management Introduces Innovative SynchroMed III Pain Pump to Its Practice

    Bux Pain Management implements SynchroMed III intrathecal drug delivery system, revolutionizing pain management therapy with enhanced safety and efficiency
    Innovative Technology Pain Management Chronic Pain Bux Pain Management SynchroMed III
    Logo of Bux Pain Management
  • PRESS RELEASE

    published on 12/12/2023 at 16:00, 2 years ago

    Bux Pain Management Welcomes Mandi Tomazic, Board-Certified Family Nurse Practitioner, to Its Esteemed Team

    Logo of Bux Pain Management
Accesswire
  • Published on 12/19/2025 at 03:15, 6 hours 52 minutes ago

    Tactical Resources Announces Receipt Of Final Order Approving Arrangement With Plum Acquisition Corp. III

  • Published on 12/19/2025 at 01:10, 8 hours 57 minutes ago

    Ostrom Climate Exits Existing UPRIIS ERPA Arrangements

  • Published on 12/19/2025 at 01:00, 9 hours 7 minutes ago

    Sun Peak Metals Announces Completion of Acquisition of Saudi Discovery Company SPV Limited

  • Published on 12/19/2025 at 00:50, 9 hours 17 minutes ago

    High Resolution Gravity Survey Targets Challenger Repeats

  • Published on 12/19/2025 at 00:00, 10 hours 7 minutes ago

    LIR Life Sciences Announces Appointment of Dr. Peter Singer as Scientific Advisor

View all ACCESSWIRE
EQS Group
  • Published on 12/19/2025 at 09:35, 31 minutes ago

    Top sports physio says football bosses failing to properly protect players' health this Christmas as injuries expected to rise

  • Published on 12/19/2025 at 09:31, 35 minutes ago

    Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY

  • Published on 12/19/2025 at 09:26, 40 minutes ago

    Original-Research: SYNBIOTIC SE (von NuWays AG): BUY

  • Published on 12/19/2025 at 09:21, 45 minutes ago

    Original-Research: Netfonds AG (von NuWays AG): BUY

  • Published on 12/19/2025 at 09:14, 52 minutes ago

    Original-Research: Bittium Oyj (von NuWays AG): BUY

View all EQS
Les Echos
  • Published on 12/19/2025 at 08:30, 1 hour 37 minutes ago

    Share capital decrease by way of treasury shares cancellation

  • Published on 12/19/2025 at 08:30, 1 hour 37 minutes ago

    Réduction du capital par voie d’annulation d’actions propres

  • Published on 12/19/2025 at 07:00, 3 hours 7 minutes ago

    EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS

  • Published on 12/19/2025 at 07:00, 3 hours 7 minutes ago

    EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

  • Published on 12/18/2025 at 18:30, 15 hours 37 minutes ago

    Schneider Electric completes transaction to acquire remaining 35% stake in existing Indian JV

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy